Overview
- 15 inspections across 15 sites are on record.
- 10 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2011-07-29.
At a glance
Inspections
15
Sites
15
Observations
10
Career since
Apr 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Agila Especialidades Farmaceuticas Ltda | 29 Jul 2011 | On file | |
| Rentschler Biopharma SE | 19 Jul 2011 | On file | |
| Hangzhou Minsheng Binjiang Pharmaceutical Co.,Ltd | 10 Jun 2011 | On file | |
| Genzyme Ireland Limited | 30 Oct 2009 | On file | |
| Sandoz GmbH | 9 Jul 2009 |
Sites inspected
Agila Especialidades Farmaceuticas LtdaRio de Janeiro, Brazil1 insp.
Rentschler Biopharma SELaupheim, Germany1 insp.
Hangzhou Minsheng Binjiang Pharmaceutical Co.,LtdHangzhou, China1 insp.
Genzyme Ireland LimitedWaterford, Ireland1 insp.
Sandoz GmbHUnterlangkampfen, Austria1 insp.
Co-investigators
Investigators who share inspections with this person.
Randy L Self3 shared
Steven C Madzo2 shared
Kevin P Foley2 shared
Parul M Patel2 shared
Maan S Abduldayem1 shared
Frank W Perrella1 shared
Carole L Jones1 shared
Full investigator report
Get the verbatim findings behind Douglas A Campbell's 10 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site